Skip to main content
. 2016 Nov 17;4(6):e00274. doi: 10.1002/prp2.274

Table 4.

Pharmacokinetic parameters for perfluorobutane (PFB) and perfluoromethylcyclopentane (PF‐MCP) measured in whole blood from the dogs. Values given are mean ± SD. No statistical differences between animals exposed or not exposed to ultrasound were detected

Group Test item Dose (mL/kg) US activation PFB PF‐MCP
C max (ng/g) AUClast (min × ng/g) Half‐life (min) Cmax (ng/g) AUClast (min × ng/g) Half‐life (min)
1 Saline 1.0 No N/A N/A N/A N/A N/A N/A
2 ACT 0.1 No 27.8 ± NC 259 ± 50.3 4.8 ± 1.5 1894 ± NC 22826 ± 2929 115 ± 5.6
3 ACT 0.3 No 69.1 ± 16.9 647 ± 128 22.1 ± 1.7 4059 ± 1143 59179 ± 15752 93.2 ± 32.1
4 ACT 1.0 No 165 ± 73.6 1660 ± 550 20.1 ± 2.4 9034 ± 4111 135960 ± 30405 54.8 ± 7.8
5 Saline 1.0 Yes N/A N/A N/A N/A N/A N/A
6 ACT 0.1 Yes 27.8 ± 3.2 295 ± 62.8 6.3 ± 4.0 2086 ± 354 34477 ± 13014 110 ± 30.4
7 ACT 0.3 Yes 53.0 ± NC 518 ± 117 21.2 ± 1.4 3868 ± NC 49019 ± 10378 69.8 ± 9.6
8 ACT 1.0 Yes 160 ± 45.8 1946 ± 413 18.9 ± 4.0 9607 ± 3937 162475 ± 34426 58.1 ± 8.4

NC: not calculable since some animals were excluded from calculations due to T max > 2 min. ACT, Acoustic Cluster Therapy.